San Diego Digestive Diseases Research Center
San Diego Digestive Diseases Research Center
批准号:
10617213
负责人:
LARS ECKMANN
金额:
$118.46万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-07-01 至 2025-04-30
关键词:
AccelerationAnimal ModelAreaBasic ScienceBiomedical ResearchCaliforniaCell Culture TechniquesClinicalClinical InvestigatorClinical ResearchCollaborationsCommunicationComplementDevelopmentDigestive System DisordersDirect CostsDiseaseEffectivenessEnvironmentFacultyFosteringFundingGastrointestinal DiseasesGastrointestinal tract structureGoalsHealthHumanImmune responseImmunityIndividualInfectionInflammationInflammatoryInflammatory Bowel DiseasesInflammatory ResponseInfrastructureInstitutionInvestmentsLaboratory ResearchLinkLiverLiver diseasesMentorsMissionNational Institute of Diabetes and Digestive and Kidney DiseasesPatient CarePhenotypePre-Clinical ModelPreventionProductivityR24ResearchResearch PersonnelResearch SupportResourcesRoleScientistSeriesServicesSpecimenSystemTechnologyTranslational ResearchUniversitiesWorkbasecareercost effectivedesignflexibilityfunctional genomicsgastrointestinalhigh riskhost-microbe interactionshuman tissueimprovedinnovationlecturesmedical schoolsmembermicrobiome researchmouse modelnext generationnovelpatient populationpreclinical studyprogramsrepositoryresearch and developmentsymposiumweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
The San Diego Digestive Diseases Research Center is founded on a research base of 33 outstanding
investigators with current digestive diseases-relevant funding of $15,689,402 in total annual direct costs, of
which $5,711,412 (36.4%) are from NIDDK. The overall mission of the Center is to support basic, translational
and clinical research that will lead to improved treatment and prevention of inflammatory diseases of the
digestive system. The primary goal of the Center is to provide services to the research laboratories of a
consortium of four adjacent research institutions in the San Diego area that will foster research productivity and
new research directions, and encourage productive collaborations. Another major goal of the San Diego
Digestive Diseases Research Center is to enhance new digestive diseases research through Pilot/Feasibility
and Enrichment programs. The Center supports three interrelated Biomedical Research Cores that are
designed to enhance the research potential and productivity of the Center members. The Human Translational
Core builds upon existing expertise in clinical and translational research to provide access to human
specimens and leverages unique existing repositories of inflammatory bowel disease and liver diseases. The
Preclinical Models Core facilitates and assists in characterizing and understanding of gastrointestinal and liver
diseases using murine models. The Microbiomics and Functional Genomics Core provides cutting-edge and
cost-effective access to sequencing-based technologies in microbiomics and functional genomics.
Furthermore, an Administrative Core supports the Center administratively and coordinates the Pilot/Feasibility
and Enrichment programs. Together, these Cores provide high-quality and state-of-the-art research resources
to increase collaborative activity and effectiveness of the members, and promote the development of junior
investigators. Combined with the Pilot/Feasibility and Enrichment programs, the San Diego Digestive Diseases
Research Center will complement a strong cadre of scientists focused on a range of important inflammatory
diseases of the gastrointestinal tract and liver. By creating a unique environment to nurture novel research
ideas and interactions, the San Diego Digestive Diseases Research Center presents a unique opportunity to
integrate clinical and bench research to advance the basic understanding of digestive diseases, and enhance
the health and care of patients suffering from those diseases.
期刊论文(58)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.3389/fmicb.2022.834008
发表时间:
2022
期刊:
Frontiers in microbiology
影响因子:
5.2
作者:
[Krakovka S, Ribacke U, Miyamoto Y, Eckmann L, Svärd S]
通讯作者:
Svärd S
DOI:
10.1099/mgen.0.000402
发表时间:
2020-08
期刊:
Microbial genomics
影响因子:
3.9
作者:
[Xu F, Jiménez-González A, Einarsson E, Ástvaldsson Á, Peirasmaki D, Eckmann L, Andersson JO, Svärd SG, Jerlström-Hultqvist J]
通讯作者:
Jerlström-Hultqvist J
DOI:
10.1111/apt.16712
发表时间:
2022-03
期刊:
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
影响因子:
7.6
作者:
[Sandborn, William J., Lawendy, Nervin, Danese, Silvio, Su, Chinyu, Loftus, Edward V., Jr., Hart, Ailsa, Dotan, Iris, Damiao, Aderson O. M. C., Judd, Donna T., Guo, Xiang, Modesto, Irene, Wang, Wenjin, Panes, Julian]
通讯作者:
Panes, Julian
DOI:
10.14309/ajg.0000000000001263
发表时间:
2021-08-01
期刊:
The American journal of gastroenterology
影响因子:
--
作者:
[Dulai PS, Jairath V, Narula N, Wong E, Kochhar GS, Colombel JF, Sandborn WJ]
通讯作者:
Sandborn WJ
DOI:
10.3390/ijms22073544
发表时间:
2021-03-29
期刊:
International journal of molecular sciences
影响因子:
5.6
作者:
[Lee J, Mohsen A, Banerjee A, McCullough LD, Mizuguchi K, Shimaoka M, Kiyono H, Park EJ]
通讯作者:
Park EJ
共 43 条
Membrane-cloaked nanoparticles as mucosal vaccines against giardiasis
-
批准号:10495210
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2021
-
负责人:LARS ECKMANN
-
依托单位:
Proteasome inhibitors against mucosal protozoan pathogens
-
批准号:10674897
-
项目类别:
-
资助金额:$64.84万
-
财政年份:2021
-
负责人:LARS ECKMANN
-
依托单位:
Proteasome inhibitors against mucosal protozoan pathogens
-
批准号:10367246
-
项目类别:
-
资助金额:$64.84万
-
财政年份:2021
-
负责人:LARS ECKMANN
-
依托单位:
Membrane-cloaked nanoparticles as mucosal vaccines against giardiasis
-
批准号:10351416
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2021
-
负责人:LARS ECKMANN
-
依托单位:
San Diego Digestive Diseases Research Center
-
批准号:10395968
-
项目类别:
-
资助金额:$118.47万
-
财政年份:2019
-
负责人:LARS ECKMANN
-
依托单位:
Selective proteasome inhibitors for trichomoniasis
-
批准号:9806764
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2019
-
负责人:LARS ECKMANN
-
依托单位:
Pilot and Feasibility Program
-
批准号:10395974
-
项目类别:
-
资助金额:$17.64万
-
财政年份:2019
-
负责人:LARS ECKMANN
-
依托单位:
Pilot and Feasibility Program
-
批准号:10617225
-
项目类别:
-
资助金额:$17.64万
-
财政年份:2019
-
负责人:LARS ECKMANN
-
依托单位:
High-potency nitro antimicrobials for topical treatment of trichomoniasis
-
批准号:9049219
-
项目类别:
-
资助金额:$35.39万
-
财政年份:2016
-
负责人:LARS ECKMANN
-
依托单位:
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists
-
批准号:8962082
-
项目类别:
-
资助金额:$63.74万
-
财政年份:2015
-
负责人:LARS ECKMANN
-
依托单位:
Next-generation 5-nitro heterocyclic antimicrobials against mucosal protists
-
批准号:9273358
-
项目类别:
-
资助金额:$62.37万
-
财政年份:2015
-
负责人:LARS ECKMANN
-
依托单位:
Mouse Model Core
-
批准号:7757167
-
项目类别:
-
资助金额:$15.55万
-
财政年份:2009
-
负责人:LARS ECKMANN
-
依托单位:
Click chemistry for novel antimicrobials against periodontal pathogens
-
批准号:7933971
-
项目类别:
-
资助金额:$47.62万
-
财政年份:2009
-
负责人:LARS ECKMANN
-
依托单位:
Click chemistry for novel antimicrobials against periodontal pathogens
-
批准号:7819386
-
项目类别:
-
资助金额:$48.54万
-
财政年份:2009
-
负责人:LARS ECKMANN
-
依托单位:
Mucosal Responses to Minimally Invasive Pathogens
-
批准号:7757159
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2009
-
负责人:LARS ECKMANN
-
依托单位:
The UCSD Digestive Diseases Research Development Center
-
批准号:7789482
-
项目类别:
-
资助金额:$54.08万
-
财政年份:2008
-
负责人:LARS ECKMANN
-
依托单位:
The UCSD Digestive Diseases Research Development Center
-
批准号:8053901
-
项目类别:
-
资助金额:$50.21万
-
财政年份:2008
-
负责人:LARS ECKMANN
-
依托单位:
The UCSD Digestive Diseases Research Development Center
-
批准号:8268140
-
项目类别:
-
资助金额:$50.21万
-
财政年份:2008
-
负责人:LARS ECKMANN
-
依托单位:
Next-generation 5-nitroimidazoles against giardiasis
-
批准号:8116019
-
项目类别:
-
资助金额:$103.63万
-
财政年份:2007
-
负责人:LARS ECKMANN
-
依托单位:
Mucosal Responses to Minimally Invasive Pathogens
-
批准号:7509283
-
项目类别:
-
资助金额:$18.56万
-
财政年份:2007
-
负责人:LARS ECKMANN
-
依托单位:
海外基金